Literature DB >> 8651296

X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene.

A Renieri1, M Bruttini, L Galli, P Zanelli, T Neri, S Rossetti, A Turco, N Heiskari, J Zhou, R Gusmano, L Massella, G Banfi, F Scolari, A Sessa, G Rizzoni, K Tryggvason, P F Pignatti, M Savi, A Ballabio, M De Marchi.   

Abstract

The COL4A5 gene encodes the alpha5 (type IV) collagen chain and is defective in X-linked Alport syndrome (AS). Here, we report the first systematic analysis of all 51 exons of COL4A5 gene in a series of 201 Italian AS patients. We have previously reported nine major rearrangements, as well as 18 small mutations identified in the same patient series by SSCP analysis of several exons. After systematic analysis of all 51 exons of COL4A5, we have now identified 30 different mutations: 10 glycine substitutions in the triple helical domain of the protein, 9 frameshift mutations, 4 in-frame deletions, 1 start codon, 1 nonsense, and 5 splice-site mutations. These mutations were either unique or found in two unrelated families, thus excluding the presence of a common mutation in the coding part of the gene. Overall, mutations were detected in only 45% of individuals with a certain or likely diagnosis of X-linked AS. This finding suggests that mutations in noncoding segments of COL4A5 account for a high number of X-linked AS cases. An alternative hypothesis is the presence of locus heterogeneity, even within the X-linked form of the disease. A genotype/phenotype comparison enabled us to better substantiate a significant correlation between the degree of predicted disruption of the alpha5 chain and the severity of phenotype in affected male individuals. Our study has significant implications in the diagnosis and follow-up of AS patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8651296      PMCID: PMC1915065     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  38 in total

1.  [Growth disorders after injury of the epiphyses in children].

Authors:  W MOL
Journal:  Ned Tijdschr Geneeskd       Date:  1962-02-03

2.  Detection of 12 novel mutations in the collagenous domain of the COL4A5 gene in Alport syndrome patients.

Authors:  E Boye; F Flinter; J Zhou; K Tryggvason; M Bobrow; A Harris
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

3.  How to find all those mutations.

Authors:  S Forrest; R Cotton; U Landegren; E Southern
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330

4.  How neutral are synonymous codon mutations?

Authors:  I Richard; J S Beckmann
Journal:  Nat Genet       Date:  1995-07       Impact factor: 38.330

5.  Genetic heterogeneity of Alport syndrome.

Authors:  J Feingold; E Bois; A Chompret; M Broyer; M C Gubler; J P Grünfeld
Journal:  Kidney Int       Date:  1985-04       Impact factor: 10.612

6.  Ocular manifestations of Alport's syndrome: a hereditary disorder of basement membranes?

Authors:  J A Govan
Journal:  Br J Ophthalmol       Date:  1983-08       Impact factor: 4.638

7.  Comparative distribution of the alpha 1(IV), alpha 5(IV), and alpha 6(IV) collagen chains in normal human adult and fetal tissues and in kidneys from X-linked Alport syndrome patients.

Authors:  B Peissel; L Geng; R Kalluri; C Kashtan; H G Rennke; G R Gallo; K Yoshioka; M J Sun; B G Hudson; E G Neilson
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

8.  A novel missense mutation in exon 3 of the COL4A5 gene associated with late-onset Alport syndrome.

Authors:  A E Turco; S Rossetti; M O Biasi; G Rizzoni; L Massella; N H Saarinen; A Renieri; P F Pignatti; M De Marchi
Journal:  Clin Genet       Date:  1995-11       Impact factor: 4.438

9.  Analysis of the OA1 gene reveals mutations in only one-third of patients with X-linked ocular albinism.

Authors:  M V Schiaffino; M T Bassi; L Galli; A Renieri; M Bruttini; F De Nigris; A A Bergen; S J Charles; J R Yates; A Meindl
Journal:  Hum Mol Genet       Date:  1995-12       Impact factor: 6.150

10.  Major COL4A5 gene rearrangements in patients with juvenile type Alport syndrome.

Authors:  A Renieri; L Galli; A Grillo; M Bruttini; T Neri; P Zanelli; G Rizzoni; L Massella; A Sessa; M Meroni; L Peratoner; P Riegler; F Scolari; M Mileti; M Giani; M Cossu; M Savi; A Ballabio; M De Marchi
Journal:  Am J Med Genet       Date:  1995-11-20
View more
  20 in total

1.  Normal distribution of collagen IV in renal basement membranes in Epstein's syndrome.

Authors:  I Naito; S Nomura; S Inoue; M Kagawa; S Kawai; Y Gunshin; K Joh; C Tsukidate; Y Sado; G Osawa
Journal:  J Clin Pathol       Date:  1997-11       Impact factor: 3.411

Review 2.  Alport's syndrome.

Authors:  F Flinter
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

3.  Alport syndrome in a Kazakh family: a case study.

Authors:  Elena V Zholdybayeva; Saule E Rakhimova; Barshagul T Baikara; Nazym B Nigmatullina; Nagima M Mustapayeva; Kuvat T Momynaliev
Journal:  J Genet       Date:  2014-12       Impact factor: 1.166

4.  Topoisomerase I and II consensus sequences in a 17-kb deletion junction of the COL4A5 and COL4A6 genes and immunohistochemical analysis of esophageal leiomyomatosis associated with Alport syndrome.

Authors:  Y Ueki; I Naito; T Oohashi; M Sugimoto; T Seki; H Yoshioka; Y Sado; H Sato; T Sawai; F Sasaki; M Matsuoka; S Fukuda; Y Ninomiya
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

5.  Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys.

Authors:  L Heidet; Y Cai; L Guicharnaud; C Antignac; M C Gubler
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

6.  Characterisation and genetic mapping of a new X linked deafness syndrome.

Authors:  D M Martin; F J Probst; S A Camper; E M Petty
Journal:  J Med Genet       Date:  2000-11       Impact factor: 6.318

7.  The importance of non-invasive genetic analysis in the initial diagnostics of Alport syndrome in young patients.

Authors:  Maja Slajpah; Anamarija Meglic; Polonca Furlan; Damjan Glavac
Journal:  Pediatr Nephrol       Date:  2005-06-08       Impact factor: 3.714

8.  Detection of large deletion mutations in the COL4A5 gene of female Alport syndrome patients.

Authors:  Kandai Nozu; Rafal Przybyslaw Krol; Yasufumi Ohtsuka; Koichi Nakanishi; Norishige Yoshikawa; Yoshimi Nozu; Hiroshi Kaito; Kyoko Kanda; Yuya Hashimura; Yuhei Hamasaki; Kazumoto Iijima; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2008-06-27       Impact factor: 3.714

9.  Prognostic value of glomerular collagen IV immunofluorescence studies in male patients with X-linked Alport syndrome.

Authors:  Laura Massella; Concetta Gangemi; Kostas Giannakakis; Antonella Crisafi; Tullio Faraggiana; Chiara Fallerini; Alessandra Renieri; Andrea Onetti Muda; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-31       Impact factor: 8.237

10.  Comparative analysis of the noncollagenous NC1 domain of type IV collagen: identification of structural features important for assembly, function, and pathogenesis.

Authors:  K O Netzer; K Suzuki; Y Itoh; B G Hudson; R G Khalifah
Journal:  Protein Sci       Date:  1998-06       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.